Aqr Capital Management LLC Gilead Sciences, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 1,943,072 shares of GILD stock, worth $180 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

1,943,072

Previous 2,053,073 5.36%

Holding current value

$180 Million

Previous $141 Million 15.62%

% of portfolio

0.23%

Previous 0.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $7.32 Million - $9.24 Million	-110,001 Reduced 5.36%	1,943,072 $163 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $79.7 Million - $91.9 Million	-1,261,631 Reduced 38.06%	2,053,073 $141 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $39.3 Million - $48 Million	-549,472 Reduced 14.22%	3,314,704 $243 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $66.6 Million - $75.6 Million	-909,512 Reduced 19.05%	3,864,176 $313 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $39.3 Million - $42.9 Million	531,314 Added 12.52%	4,773,688 $358 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $55.6 Million - $63.4 Million	731,362 Added 20.83%	4,242,374 $327 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $20 Million - $22.8 Million	-259,147 Reduced 6.87%	3,511,012 $291 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $109 Million - $156 Million	-1,743,093 Reduced 31.62%	3,770,159 $324 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $34.7 Million - $39.6 Million	-582,541 Reduced 9.56%	5,513,252 $340 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $195 Million - $220 Million	3,383,767 Added 124.77%	6,095,793 $376 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $85.8 Million - $108 Million	1,482,141 Added 120.51%	2,712,026 $161 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $5.99 Million - $6.8 Million	92,279 Added 8.11%	1,229,885 $89.3 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $1.27 Million - $1.37 Million	-18,824 Reduced 1.63%	1,137,606 $79.5 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $51.7 Million - $56.5 Million	-814,483 Reduced 41.33%	1,156,430 $79 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $60 Million - $68.5 Million	-1,000,300 Reduced 33.67%	1,970,913 $127 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $44.5 Million - $50.8 Million	-786,288 Reduced 20.93%	2,971,213 $169 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $56.1 Million - $70.5 Million	-903,477 Reduced 19.38%	3,757,501 $235 Million
Q2 2020 Aug 17, 2020	SELL	$72.34 - $84.0 $82.2 Million - $95.5 Million	-1,136,461 Reduced 19.6%	4,660,978 $353 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $88.4 Million - $113 Million	-1,411,277 Reduced 19.58%	5,797,439 $433 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $165 Million - $182 Million	2,682,046 Added 59.25%	7,208,716 $465 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $55.7 Million - $61.5 Million	-891,623 Reduced 16.46%	4,526,670 $287 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $219 Million - $245 Million	-3,538,186 Reduced 39.5%	5,418,293 $363 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $17.9 Million - $20 Million	285,954 Added 3.3%	8,956,479 $582 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $19.8 Million - $25.8 Million	326,298 Added 3.91%	8,670,525 $542 Million
Q3 2018 Nov 15, 2018	SELL	$71.28 - $78.92 $38.9 Million - $43.1 Million	-545,884 Reduced 6.14%	8,344,227 $644 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $114 Million - $133 Million	-1,763,758 Reduced 16.56%	8,890,111 $630 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $144 Million - $176 Million	-1,978,920 Reduced 15.66%	10,653,869 $803 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $36.7 Million - $43.1 Million	516,486 Added 4.26%	12,632,789 $905 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $874 Million - $1.04 Billion	12,116,303	12,116,303 $982 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Gilead Sciences, Inc. Transaction History